Day: March 7, 2024

Octopus Titan VCT plc Portfolio Manager Changes Octopus Titan VCT plc (‘Titan’ or ‘the Company’) announces a change of lead fund manager at the Company’s Portfolio Manager, Octopus Investments Limited (‘Octopus’) following the resignation of Malcolm Ferguson, the current lead fund manager. With immediate effect, Jo Oliver has been appointed as Advisor to the Board on Fund & Strategy on an interim basis. Jo brings 15 years of experience with Octopus Ventures and the Company, having previously been the lead fund manager for Titan from November 2014 to June 2022. Since 2022, Jo has remained part of the Octopus Ventures investment team (as a Partner) on a part-time basis. Malcolm will continue to take an active role as lead fund manager of Titan until 30 April 2024, with Jo then taking on the interim role overseeing the fund management...

Get savings on Verizon’s new service that gives you the ability to add a second number on one phone NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) — If you’ve ever wanted access to more than one phone number without having to carry around a separate cell phone and pay a full-price plan, Verizon has you covered. Today, Verizon announced the launch of Second Number1, a new plan that allows customers to get a second unlimited talk and text lines on their same phone for a limited-time cost of just $10 per month. Why we’re launching Second Number: Customers increasingly use two phone numbers to manage their busy lives. From safely selling on online marketplaces to operating side gigs, to replacing landlines or getting a special number just for family, customers want access to a second phone number—and often, get a second phone to do so. With...

Neogen Ionics Ltd and noco-noco Inc (via noco-tech), Singapore, collaborates at Rechargeable Battery Expo, Tokyo.noco-tech, Japan and Neogen Ionics, India, collaborate to showcase noco-noco’s X-SEPA(TM) and other Neogen products at Battery Japan. From left Kawai San, Mr Metha, Ms Kadam and Moriya San.Highlights:Neogen secured a 3-year marketing and distribution license for noco-noco’s X-SEPA™ technology with the eventual objective to manufacture X-SEPA™ separators in India. The combined technological synergies blending noco-noco’s revolutionary X-SEPA™ separator technology with Neogen’s electrolyte, will provide pioneering solutions to a wider clientele. noco-noco (NASDAQ: NCNC), aims to swiftly penetrate the rapidly growing Indian electric mobility and energy storage market leveraging...

Aktia Bank PlcStock Exchange Release7 March 2024 at 4.30 p.m.         Correction to Stock Exchange Release: Notice to Aktia Bank Plc’s Annual General Meeting 2024 Typing errors in section C1. have been corrected. Notice is hereby given to Aktia Bank Plc shareholders that the Annual General Meeting will be held on Wednesday, 3 April 2024 at 4.00 p.m. at Pikku-Finlandia, address Karamzininranta 4, Helsinki. Persons who have registered for the meeting will be welcomed and voting sheets will be distributed from 3.00 p.m. onwards. Shareholders of Aktia Bank Plc can also exercise their voting rights by voting in advance. Instructions for advance voting are set out in section C of this notice to the Annual General Meeting. It is possible to follow the Annual General Meeting via webcast. Instructions on how to follow the webcast are available...

ST. PETERSBURG, Fla., March 07, 2024 (GLOBE NEWSWIRE) — In a significant move for its shareholders, The Marquie Group, Inc. (OTCMKTS:TMGI), an emerging leader in health and beauty sector, today declared its intention to decrease its number of authorized shares. Marc Angell, CEO of The Marquie Group, remarked, “By continuing to eliminate debt, we’re in a position to reclaim reserve shares back into the treasury. This action enables us to significantly reduce the number of authorized shares.” He further commented, “This reduction is expected to enhance shareholder confidence considerably.” About The Marquie Group, Inc. The Marquie Group is known for its Whim brand, a line of health and beauty products that promise safety, efficacy, and quality. Whim products are available through various channels including SimplyWhim.com, Amazon,...

Figure 1Permits obtainedTORONTO, March 07, 2024 (GLOBE NEWSWIRE) — Forsys Metals Corp. (TSX: FSY) (FSE: F2T) (NSX: FSY) (“Forsys” or the “Company”) is pleased to announce that the Ministry of Mines and Energy of the Republic of Namibia (“Ministry”) has renewed the Company’s Namibplaas Exclusive Prospecting License (“EPL”)– 3638, that forms part of its Norasa Uranium Project (“Norasa1”). This licence has been renewed for a further two years until February 2026. In September 2022 Forsys has also made an application to the Ministry to convert EPL-3638 to a full 25-year Mining Licence (“ML”), and this submission is pending as ML-251. EPL-3638 remains in good standing while the Ministry processes Forsys’ ML-251 submission. “EPL-3638 covers a strategic land position with significant exploration upside,” commented Pine...

Trust Stamp announces a new AI-Powered transaction authorization service for banking and other high value and high risk transactions Atlanta, GA, March 07, 2024 (GLOBE NEWSWIRE) — Trust Stamp (Nasdaq: IDAI), the Privacy-First Identity CompanyTM announced the launch of Trusted Authentication™, a transaction authorization service providing identity authentication for high-value financial transactions initiated online. Gareth N. Genner, Trust Stamp’s President commented, “The recent increase in deep-fake attacks has exposed fundamental weaknesses in many legacy systems, requiring additional assurance for high value and high risk transactions such as wire transfers. Trusted Authentication ensures the identity and live-presence of an authorizing party and can be integrated into or used in parallel to existing approval systems....

Company presenting an in vivo study of PT-CD16, a genetically modified allogeneic cell therapy derived from human placental circulating T (P-T) cells at AACR Annual Meeting 2024 FLORHAM PARK, N.J., March 07, 2024 (GLOBE NEWSWIRE) — Celularity Inc. (NASDAQ: CELU) (“Celularity”), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial products, announced today that it will present in vivo data from its T-cell therapy platform at this year’s AACR Annual Meeting. These data, which highlight the platform’s robust anti-tumor activity against gastric cancer will be presented on April 9th, 2024. Please find the link to the abstract here. Celularity is developing a platform to combine a broad portfolio of cell therapies with various approved antibodies to address multiple cancers and other conditions....